Australia's Nanostructural Analysis Network Organisation (NANO) was established four years ago to provide top-tier microscopy services for Australian scientists.

The spectacular images Brad Marsh is able to capture using NANO's cryo-transmission electron microscope are teaching us more about pancreatic beta cells. Fiona Wylie spoke to the man behind the microscope.

The Australian Stock Exchange has created a market that attracts not only local biotechnology companies, but also gives opportunities to foreign companies that would be unable to attract capital in their own markets. Helen Schuller reports.

Drug developer Phylogica (ASX:PYC) and artificial heart company Sunshine Heart (ASX:SHC) have been awarded a Commercial Ready grants from AusIndustry, worth $2.27 million and $2.223 million respectively.

The second patient to receive Sunshine Heart's (ASX:SHC) C-Pulse device has had the device removed one month after it was implanted, after he developed a related infection.

Doctors at Auckland City Hospital have conducted the first long-term implant of a Sunshine Heart (ASX:SHC) C-Pulse heart device in a 56-year old New Zealand man.

Malaria is not just an abstraction for Kenyan researcher Lucy Ochola. As an infant, she contracted malaria, and survived. She was lucky -- in the western highlands of her homeland, infant mortality from malaria approaches 30 per cent.